AUTHORS
Grigorios Gerotziafas
Associate Professor of Hematology at the Faculty of Medicine, University Pierre et Marie Curie (Paris, France).
Professor Gerotziafas leads the Thrombosis and Hemostasis Sector in the Service d’Hématologie Biologique of Tenon University Hospital in Paris (France) and the research group of Cancer Hemostasis and Angiogenesis in INSERM Paris VI.
His research activity focuses on interactions between cancer cells and blood coagulation and on the pharmacology and the mechanism of action of heparins and the direct oral anticoagulants. Other interests are the prevention of venous thromboembolism, optimization of antithrombotic treatment, risk assessment of venous thromboembolism in cancer patients and the management of infertility and vascular complications of pregnancy.
He chairs the Hellenic consensus statements for the prophylaxis and treatment of venous thromboembolism, and he is a member of the Scientific and Standardization Committee for Control of Anticoagulation of the International Society on Thrombosis and Hemostasis. He has published extensively in peer-reviewed international journals and has authored several book chapters. He sits on the review boards of several international journals and is member of several professional societies.
Professor Gerotziafas leads the Thrombosis and Hemostasis Sector in the Service d’Hématologie Biologique of Tenon University Hospital in Paris (France) and the research group of Cancer Hemostasis and Angiogenesis in INSERM Paris VI.
His research activity focuses on interactions between cancer cells and blood coagulation and on the pharmacology and the mechanism of action of heparins and the direct oral anticoagulants. Other interests are the prevention of venous thromboembolism, optimization of antithrombotic treatment, risk assessment of venous thromboembolism in cancer patients and the management of infertility and vascular complications of pregnancy.
He chairs the Hellenic consensus statements for the prophylaxis and treatment of venous thromboembolism, and he is a member of the Scientific and Standardization Committee for Control of Anticoagulation of the International Society on Thrombosis and Hemostasis. He has published extensively in peer-reviewed international journals and has authored several book chapters. He sits on the review boards of several international journals and is member of several professional societies.